Cargando…
Massive Accumulation of Glycosaminoglycans in the Aortic Valve of a Patient With Hunter Syndrome During Enzyme Replacement Therapy
This report describes the pathologic findings for a patient with Hunter syndrome who underwent aortic valve replacement at 10 years of age, 3 years after the initiation of enzyme replacement therapy. Aortic valve pathology showed mild thickening and fibrosis as well as massive glycosaminoglycan accu...
Autores principales: | Sato, Yohei, Fujiwara, Masako, Kobayashi, Hiroshi, Ida, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825558/ https://www.ncbi.nlm.nih.gov/pubmed/23404265 http://dx.doi.org/10.1007/s00246-013-0653-0 |
Ejemplares similares
-
Residual glycosaminoglycan accumulation in mitral and aortic valves of a patient with attenuated MPS I (Scheie syndrome) after 6 years of enzyme replacement therapy: Implications for early diagnosis and therapy
por: Sato, Yohei, et al.
Publicado: (2015) -
Double Valve Replacement in a Patient With Hunter Syndrome
por: Keshavamurthy, Suresh, et al.
Publicado: (2022) -
Perioperative airway management for aortic valve replacement in an adult with mucopolysaccharidosis type II (Hunter syndrome)
por: Suzuki, Kazuchika, et al.
Publicado: (2018) -
The role of enzyme replacement therapy in severe Hunter syndrome—an expert panel consensus
por: Muenzer, Joseph, et al.
Publicado: (2011) -
Immune Modulation for Enzyme Replacement Therapy in A Female Patient With Hunter Syndrome
por: Julien, Daniel C., et al.
Publicado: (2020)